Advanced International Journal for Research
E-ISSN: 3048-7641
•
Impact Factor: 9.11
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with AIJFR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 6 Issue 6
November-December 2025
Indexing Partners
Formulation Development Studies
| Author(s) | Mr. Sujit Annappa Waghmare, Ms. Hema Suresh Chougule, Ms. Rupali kudlik Ghute |
|---|---|
| Country | India |
| Abstract | Formulation development plays a critical role in transforming an active pharmaceutical ingredient (API) into a safe, effective, and patient friendly dosage form. The present work focuses on the systematic design, optimization, and evaluation of a pharmaceutical formulatio aimed at improving the stability, bioavailability, and therapeutic performance of the selected drug. Pre-formulation studies were conducted to assess physicochemical properties, compatibility with excipients, and critical material attributes influencing product performance. Various prototype formulations were developed using a Quality by Design (QbD) approach, and key process parameter were optimized to achieve the desired critical quality attributes. The optimized formulation was evaluated for physicochemical characteristics, drug release behavior, stability, and overall product performance in accordance with regulatory guidelines. Results demonstrated that the finalized formulation meets all predefined quality standards and offers improved therapeutic efficacy compared t conventional preparations. This study highlights the importance of systematic formulation development in ensuring product quality an enhancing patient outcomes. |
| Keywords | Pre-Formulation, NDDS |
| Field | Medical / Pharmacy |
| Published In | Volume 6, Issue 6, November-December 2025 |
| Published On | 2025-12-05 |
| DOI | https://doi.org/10.63363/aijfr.2025.v06i06.2187 |
| Short DOI | https://doi.org/hbdsvc |
Share this

E-ISSN 3048-7641
CrossRef DOI is assigned to each research paper published in our journal.
AIJFR DOI prefix is
10.63363/aijfr
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.